Reduction of hematopoietic cell-specific tyrosine phosphatase SHP-1 gene expression in natural killer cell lymphoma and various types of lymphomas/leukemias: Combination Analysis with cDNA expression array and tissue microarray

American Journal of Pathology

Volumn 159, Issue 4, 2001, Pages 1495-1505

  Oka, Takashi ^a   Yoshino, Tadashi ^a   Hayashi, Kazuhiko ^a   Ohara, Nobuya ^a   Nakanishi, Tohru ^a   Yamaai, Yuichiro ^a   Hiraki, A ^a   Aoki Sogawa, Chiharu Aoki ^a   Kondo, Eisaku ^a   Teramoto, N ^a   Takahashi, Kiyoshi ^a   Tsuchiyama, Junjiro ^b   Akagi, Tadaatsu ^a  

^a OKAYAMA UNIVERSITY   (Japan)

^b NIIGATA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN TYROSINE PHOSPHATASE;

ARTICLE; DNA MICROARRAY; ENZYME SPECIFICITY; GENE EXPRESSION REGULATION; GENE REARRANGEMENT; HEMATOPOIETIC CELL; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LEUKEMIA; LYMPHOMA; MALIGNANT TRANSFORMATION; METHYLATION; MOLECULAR RECOGNITION; MONONUCLEAR CELL; NATURAL KILLER CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0034790737     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)62535-7     Document Type: Article

References (48)

1. A revised European-American classification of lymphoid neoplasm: A proposal from the International Lymphoma Study Group
2. Report of the workshop on the nasal and related extranodal angiocentric T/natural killer cell lymphoma
3. The pathogenesis of Burkitt's lymphoma
4. Chromosomal translocations cause deregulated BCL6 expression by promoter substitution in B cell lymphoma
5. Detection of the t(14;18) chromosomal translocation by interphase cytogenetics with yeast-artificial-chromosome probes on follicular lymphoma and nonneoplastic lymphoproliferation
6. Overexpression of PRAD1 in a mantle zone lymphoma patient with a t(11;22)(q13;q11) translocation
7. Frequent translocation t(4;14)(p16.3;q32.3) in multiple myeloma is associated with increased expression and activating mutations of fibroblast growth factor receptor 3
8. Gene expression profiles in normal and cancer cells
9. Monitoring gene expression profile changes in ovarian carcinomas using cDNA microarray
10. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
11. Expression profiling using cDNA microarrays
12. Tissue microarrays for high-throughput molecular profiling of tumor specimens
13. Tissue microarrays for gene amplification surveys in many different tumor types
14. High-throughput tissue microarray analysis to evaluate genes uncovered by cDNA microarray screening in renal cell carcinoma
15. Characterization of a novel natural killer-cell line (NK-YS) established from natural killer cell lymphoma/leukemia associated with Epstein-Barr virus infection
16. Description of an in situ hybridization methodology for detection of Epstein-Barr virus RNA in paraffin-embedded tissues with a survey of normal and neoplastic tissues
17. Malignant lymphoma induction in rabbits by intravenous inoculation of Epstein-Barr-virus related herpesvirus from HTLV-II-transformed cynomolgus leukocyte cell line (Si-IIA)
18. Isoform-specific expression and function of neuregulin
19. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedure and some applications
20. Downregulated expression of SHP-1 in Burkitt lymphomas and germinal center B lymphocytes
21. Killer cell inhibitory receptors: Diversity, specificity, and function
22. Regulation of B cell signal transduction by SH2-containing protein-tyrosine phosphatase
23. Positive versus negative signaling by lymphocyte antigen receptors
24. Regulation of immune responses through inhibitory receptors
25. Dephosphorylation of ZAP70 and inhibition of T cell activation by activated SHP1
26. Signaling capacity of the T cell antigen receptor is negatively regulated by the PTP1C tyrosine phosphatase
27. Recruitment of SH2-containing protein tyrosine phosphatase SHP-1 to the interleukin 2 receptor: Loss of SHP-1 expression in human T-lymphotropic virus type I-transformed T cells
28. SHP-1 phosphatase C-terminus interacts with novel substrates p32/p30 during erythropoietin and interleukin-3 mitogenic responses
29. SHP1 and SHP2 protein-tyrosine phosphatases associate with betac after interleukin-3-induced receptor tyrosine phosphorylation: Identification of potential binding sites and substrates
30. SHP1 protein tyrosine phosphatase negatively modulates erythroid differentiation and suppression of apoptosis in J2E erythroleukemic cells
31. Definition of the sites of interaction between the protein tyrosine phosphatase SHP-1 and CD22
32. Polygenic autoimmune traits: Lyn, CD22, and SHP-1 are limiting elements of a biochemical pathway regulating BCR signaling and selection
33. Regulation of B cell antigen receptor signaling by the Lyn/CD22/SHP1 pathway
34. SLP-76 is a direct substrate of SHP-1 recruited to killer cell inhibitory receptors
35. Hematopoietic cell phosphatase, SHP-1, is constitutively associated with the SH2 domain-containing leukocyte protein, SLP-76, in B cells
36. The B-cell transmembrane protein CD72 binds to and is an in vive substrate of the protein tyrosine phosphatase SHP-1
37. BLNK is associated with the CD72/SHP-1/Grb2 complex in the WEHI231 cell line after membrane IgM cross-linking
38. Specificity of the SH2 domains of SHP-1 in the interaction with the immunoreceptor tyrosine-based inhibitory motif-bearing receptor gp49B
39. Lack of SHPTP1 results in src-family kinase hyperactivation and thymocyte hyperresponsiveness
40. Signaling capacity of the T cell antigen receptor is negatively regulated by the PTP1C tyrosine phosphatase
41. Killer cell inhibitory receptor recognition of human leukocyte antigen (HLA) class I blocks formation of a pp36/PLC-gamma signaling complex in human natural killer (NK) cells
42. Expression of dominant-negative src-homology domain 2-containing protein tyrosine phosphatase-1 results in increased Syk tyrosine kinase activity and B cell activation
43. Early signaling via inhibitory and activating NK receptors
44. Mutations at the murine motheaten locus are within the hematopoietic cell protein-tyrosine phosphatase (Hcph) gene
45. Identification of PTP1C mutation as the genetic defect in motheaten and viable motheaten mice: A step toward defining the roles of protein tyrosine phosphatases in the regulation of hemopoietic cell differentiation and function
46. SHP1 protein tyrosine phosphatase negatively modulates erythroid differentiation and suppression of apoptosis in J2E erythroleukemic cells
47. Involvement of the SHP1 tyrosine phosphatase in regulating B lymphocyte antigen receptor signaling, proliferation, and transformation
48. Lack of phosphotyrosine phosphatase SHP-1 expression in malignant T-cell lymphoma cells results from methylation of the SHP-1 promoter